Nested matched case control study for the Japan Fukushima Health Management Survey's first full-scale (second-round) thyroid examination.
Journal
Medicine
ISSN: 1536-5964
Titre abrégé: Medicine (Baltimore)
Pays: United States
ID NLM: 2985248R
Informations de publication
Date de publication:
02 Jul 2020
02 Jul 2020
Historique:
entrez:
8
7
2020
pubmed:
8
7
2020
medline:
18
7
2020
Statut:
ppublish
Résumé
Since Fukushima nuclear accident in 2011, thyroid ultrasound examinations have been conducted. The first full-scale examination detected 71 thyroid-cancer cases. This study examined whether radiation exposure was associated with thyroid-cancer incidence.Subjects were participants in the baseline screening and newborns during the 2011 fiscal year. Under nested matched case-control study design, 10 controls per each case were selected by matching the age, sex, baseline screening results, and interval between examinations. With 3 dose levels of external radiation: 1.3 + mSv (upper), 0.8 to 1.3 (middle), and 0.0 to 0.8 (reference), we applied 2 logistic models adjusting for 3 participation-proportions (primary, secondary, and fine-needle aspiratory cytology), overweight, and the B-result of baseline screening (Model 1), and past medical history, family history of thyroid cancer, and frequencies of eating seafood and seaweed in addition to the parameters in Model 1 (Model 2). We examined each model in 3 ways: (a) excluding subjects with a missing radiation exposure dose; and substituting (b1) median or (b2) mean dose of the municipality with missing dose.Odds ratios (ORs) of middle-dose exposure were (a) 1.35 (0.46-3.94), (b1) 1.55 (0.61-3.96), and (b2) 1.23 (0.50-3.03) for Model 1, and (a) 1.18 (0.39-3.57), (b1) 1.31 (0.49-3.49), and (b2) 1.02 (0.40-2.59) for Model 2. For upper-dose exposure, similar results were obtained. Past medical history was significantly associated (odds ratio = 2.04-2.08) with both (b1) and (b2) in Model 2.No significant associations were obtained between the external radiation exposure and thyroid-cancer incidence.
Identifiants
pubmed: 32629628
doi: 10.1097/MD.0000000000020440
pii: 00005792-202007020-00007
pmc: PMC7337421
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e20440Références
J Epidemiol. 2012;22(5):375-83
pubmed: 22955043
Jpn J Clin Oncol. 2015 Sep;45(9):884-91
pubmed: 26142437
Jpn J Clin Oncol. 2016 Mar;46(3):284-6
pubmed: 26755830
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2575-2583
pubmed: 28323979
Int J Cancer. 2018 Nov 1;143(9):2145-2149
pubmed: 29355960
Radiat Prot Dosimetry. 2012 Sep;151(3):489-99
pubmed: 22416255
Proc Jpn Acad Ser B Phys Biol Sci. 2015;91(3):92-8
pubmed: 25765011
Medicine (Baltimore). 2016 Aug;95(35):e4472
pubmed: 27583855
Radiat Res. 2006 Jan;165(1):1-8
pubmed: 16392956
J Clin Endocrinol Metab. 2018 Mar 1;103(3):861-869
pubmed: 29253182
Sci Rep. 2018 Dec 5;8(1):17661
pubmed: 30518765
Epidemiology. 2016 May;27(3):316-22
pubmed: 26441345
Medicine (Baltimore). 2017 Dec;96(48):e8631
pubmed: 29310337
Proc Jpn Acad Ser B Phys Biol Sci. 2013;89(4):157-63
pubmed: 23574806
Epidemiology. 2018 Jul;29(4):e32-e34
pubmed: 29634592
Sci Rep. 2013;3:1670
pubmed: 23591638
J Radiat Res. 2016 Aug;57 Suppl 1:i118-i126
pubmed: 27538842
Sci Rep. 2015 Aug 04;5:12712
pubmed: 26239643
Nature. 1992 Sep 3;359(6390):21
pubmed: 1522879
J Radiol Prot. 2017 Sep 25;37(3):584-605
pubmed: 28617669
Clin Pediatr Endocrinol. 2011 Apr;20(2):47-9
pubmed: 23926394